QHSLab, Inc.

USAQ ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $457.4K $-259.2K $-468.4K $-996.0K $-770.2K $-327.4K $-166.5K $-38.6K
Depreciation & Amortization $90.7K $146.6K $146.6K $128.0K $36.1K — — —
Depreciation — — — — — — — —
Amortization $72.1K $72.1K $72.1K — — — — —
Stock-Based Compensation $0 $0 $6.0K $30.1K $35.7K $7.1K — —
Net Cash from Operating Activities $178.1K $142.4K $-159.6K $-351.0K $-354.7K $-165.6K $-134.8K $-39.5K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — $-37.1K $-154.6K $-31.7K — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $300.9K $-36.9K $32.5K $280.0K $701.8K $268.0K $158.4K $39.5K
Net Change in Cash $479.0K $105.6K $-127.1K $-108.2K $192.5K $70.8K $23.6K —
Free Cash Flow — — — — — — — —
← Newer Page 1 of 2 Older →